Cell-surface glycoprotein D-galactose-containing glycans

Cell-surface glycoprotein D-galactose-containing glycans are carbohydrate structures covalently attached to proteins on the outer leaflet of the plasma membrane. These glycans typically feature terminal or internal D-galactose residues, often linked via β-glycosidic bonds (e.g., Galβ1-4GlcNAc), which serve as critical recognition motifs for various endogenous and exogenous proteins. Biologically, they play essential roles in cell-cell communication, adhesion, and the regulation of glycoprotein half-life via receptors like the asialoglycoprotein receptor (ASGPR). In a pharmacological context, these glycans are the primary targets for potent toxins such as ricin and abrin, which utilize their B-chains to bind galactose residues and facilitate cellular entry. They are also targeted by therapeutic lectins, such as those from mistletoe, and are being explored as targets for site-specific drug delivery and cancer diagnostics due to their altered expression in malignant cells. The ubiquity of these glycans on human cells presents a significant challenge for therapeutic targeting, often requiring the use of specific linkages or clusters to achieve selectivity. Furthermore, these glycans can serve as attachment factors for various pathogens, including viruses and bacteria, facilitating infection.

Other names

β-galactoside-containing glycansGalactose-terminated glycansGalactosyl-glycansRicin-binding glycansCell-surface glycoprotean D-galactose-containing glycans

Binding of lectins or toxins to terminal or internal galactose residues on cell-surface glycoproteins, often leading to receptor-mediated endocytosis and subsequent cellular effects such as protein synthesis inhibition (in the case of toxins).